You can now also collect your epPoints codes via the Eppendorf App!
In the Eppendorf App, you can now enter epPoints codes manually or scan the printed QR code. At the push of a button, the camera of your mobile device opens and you can scan the QR code. This process can be repeated quickly and easily, thus facilitating the collection of epPoints.
Try it out now!
Find more information here
To download the app, visit: www.eppendorf.com/app
The second issue of Off the Bench, the LifeScienceStyle Magazine by Eppendorf, is here.
The second issue of Off the Bench, the LifeScienceStyle Magazine by Eppendorf, is here. Our new title story features the Spanish biochemist Oscar Fernandez-Capetillo, who researches the connection between DNA damage, replicative cellular stress and the development of cancer at the National Cancer Research Center (CNIO) in Madrid. Further topics in this issue include a critical look at the genome editing process CRISPR as well as the global extinction of red algae species, the source of the gelling agent agar-agar. This issue’s travel destination is the Swiss metropolis of Geneva, host to this year’s trade fair ESHRE of the European Society of Human Reproduction and Embryology, held in early July. Lastly, with the kind permission of the journal Science, author Jeffrey J. McDonnell explains what authors of scientific publications may learn from Hollywood directors.
“After the many positive responses to our inaugural issue, we are very pleased to once again offer our readers valuable insights for their daily work routine with this new issue”, states Thomas Bachmann, President & CEO of the Eppendorf AG.
All magazine content is also available online at www.eppendorf.com/OTB.
Do you spin tubes as well as plates in your laboratory? Are you tired of switching between different rotors or rotor buckets?
Then it’s time to look forward to the new refrigerated Centrifuge 5920 R. It offers exceptionally high capacity and, thanks to practical universal swing-bucket rotors, a considerable gain in convenience (p. 4–5).
Do you work with cell culture? Our new Cell Handling online portal provides you bundled expert knowledge on the topics of contamination, identity, and reproducibility – researched in depth by the Eppendorf cell experts.
Enjoy reading these and more articles as well as product news and detailed Application Notes in the new edition of Eppendorf BioNews!
Never miss a BioNews edition!
Since 1993, Eppendorf BioNews has been widely regarded as a highly popular source of information for researchers and scientific personnel. Browse the latest edition online at www.eppendorf.com/bionews, or subscribe to BioNews free of charge in order to receive your personal printed issue fresh off the press twice a year!
Eppendorf and the journal Science are now accepting applications for the 2017 Eppendorf & Science Prize for Neurobiology.
The annual international Eppendorf & Science Prize for Neurobiology is awarded to young scientists for their outstanding contributions to neurobiological research based on methods of molecular and cell biology. Researchers who are not older than 35 years are invited to apply by June 15, 2017. The winner and finalists are selected by a committee of independent scientists, chaired by Science’s Senior Editor, Dr. Peter Stern. The award includes a prize money of US$25,000 for the winner.
The 2016 prize was won by the Israeli-American scientist Gilad Evrony, M.D., Ph.D. from Mount Sinai Hospital (New York, USA) for his work on developing technologies to sequence and analyze the genomes of single cells from the human brain. Gilad Evrony’s research has revealed a diversity of mutations in neuronal genomes indicating that every neuron in the brain carries a unique fingerprint of somatic mutations. Such mutations can cause focal brain malformations and may have a role in other unsolved neurologic diseases. The technology also allows, for the first time, reconstruction of develop-mental lineage trees in the human brain to study how cells proliferate and migrate to build the brain.
For more about the prize and film interview with Gilad Evrony, go to www.eppendorf.com/prize.
Information and entertainment on life in the laboratory. New issues twice a year.
The new Eppendorf LifeScienceStyle Magazine “Off the Bench” will be published twice a year with a varied mix of informative and entertaining topics that focus on life in the laboratory.
This new magazine joins BioNews, the science- and application-oriented magazine from Eppendorf that has been published twice yearly since 1993. “Off the Bench”, in contrast, will focus on the topic of laboratory lifestyles. In addition to interviews with personalities from science and research, the magazine offers readers a wealth of tips, information and links – such as visitor information on the city in which the next big life science trade fair will take place.
“We want to use ‘Off the Bench’ to offer readers something new – a view beyond the horizon with well-researched, entertaining articles. In the process, our goal is to create further added value for our customers and make it possible to experience our claim of being the expert and advisor in the life sciences,” says Dr. Oliver Franz, Vice President Branding and Group Communication of Eppendorf AG.
Among other things, the first issue of “Off the Bench” will acquaint readers with the work of the cell biologist Tim Gilberger and his battle against malaria. In addition, we join chef J. Kenji López-Alt in his kitchen as he creates dishes with scientific precision and sheds new light on a number of long-held cooking myths.
You can order “Off the Bench” free of charge from email@example.com or subscribe to it online at corporate.eppendorf.com/en/news-media/newsletter-magazines. The magazine’s contents are also available on the Web at www.eppendorf.com/OTB.
Israeli-American Scientist Wins 2016 Eppendorf & Science Prize
The Israeli-American scientist Gilad Evrony, M.D., Ph.D. has won the 2016 Eppendorf & Science Prize for Neurobiology for his work on developing technologies to sequence and analyse the genomes of single cells from the human brain.
For more information about Dr. Evrony and the Prize, visit www.eppendorf.com/prize.
Eppendorf BioBLU® 0.3f and 1f single-use fermentors convince in DECHEMA® kLa performance study.
The performance of the BioBLU® 0.3f and 1f Single-Use Vessels is highlighted in an external report, which was recently published by the DECHEMA Gesellschaft für Chemische Technik und Biotechnologie e.V. (Society for Chemical Engineering and Biotechnology).
A sufficient supply of oxygen is crucial for aerobic bioprocesses. To help the users to objectively compare the performance of bioreactors in terms of oxygen transfer, the DECHEMA expert group on “Single-Use technology in biopharmaceutical manufacturing” developed a standard operating procedure for measurement of the volumetric mass transfer coefficient (kLa), and using this protocol, different manufacturers experimentally determined the kLa values of their single-use fermentors. With kLa values > 500 h-1 the Eppendorf BioBLU® 0.3f and 1f Single-Use Vessels outperformed the other lab-scale fermentors tested.
"I am looking forward to working with Eppendorf's very competent and committed global management to develop the company sustainably and successfully in the years to come."
Thomas Bachmann became Chief Executive Officer of the Eppendorf Group on August 1, 2015. Following the departure of Eppendorf's previous CEO, the company's Chief Financial Officer, Detmar Ammermann, had exercised the function of Spokesman of the Management Board on an interim basis in addition to his responsibilities as CFO.
Bachmann, who has been a member of the Eppendorf Supervisory Board since 2013, came to Eppendorf from his position as President of the Bruker BioSpin Group. He has been active in the life science sector since 2005, when he took on the overall management of the globally active Tecan Group, which is headquartered in Switzerland.
"We are very pleased that we have been able to win Thomas Bachmann as our Chief Executive Officer," said Klaus Fink, Chairman of the Supervisory Board of the Eppendorf Group. "He has demonstrated his expertise and his strategic foresight in many ways during more than 25 years of experience in international management positions."
Bachmann explains: "Eppendorf is an innovative, customer-oriented company with a strong, well-known brand and a global orientation, and it succeeds again and again in making important contributions to analytic, medical, diagnostic and life science laboratories. I am looking forward to working with Eppendorf's very competent and committed global management to develop the company sustainably and successfully in the years to come."
The latest edition of our printed newsletter features interesting product innovations: the BioFlo® 320, a flexible solution for process control in cell culture and fermentation, two handy HeatSealers for reliable sealing of different plate formats, our CryoCube® ultra-low temperature freezers as well as the Eppendorf Cell Imaging Consumables for efficient cell growth and precise fluorescence analysis.
Furthermore, you will find Application Notes, news, tips, and our popular prize competition!
- Sales increase 5.7%
- Income from operations (EBIT) of approximately €95.7 million
Hamburg, May 26, 2015 – In fiscal year 2014, the Eppendorf Group achieved sales of €531.1 million (prior year: €502.7 million), corresponding to a 5.7% increase when adjusted for currency effects. Income from operations (EBIT) rose to €95.7 million (prior year: €93.8 million), and 2014 net income declined to €65.7 million (prior year: €67.5 million).
In addition, significant capital investments were made in the further expansion of the company's sales structures and the set-up of production facilities, i.e. for the introduction of new product lines. Expenses for research and development also increased to €29.4 million (prior year: €28.2 million). The number of employees rose to 2,927 worldwide (prior year: 2,848).
Detmar Ammermann, Spokesman of the Management Board and Eppendorf's Chief Financial Officer: “The outstanding performance of our employees, our rigorous implementation of our strategies and the positive developments on the market all resulted in very positive sales growth of 5.7%. On the basis of this solid result, we will continue to pursue our strategic goals and increase customer benefit sustainably.”